Wang Y - Search Results

1

Next generation patient-derived prostate cancer xenograft models.

Lin D, Xue H, Wang Y, Wu R, Watahiki A, Dong X, Cheng H, Wyatt AW, Collins CC, Gout PW, Wang Y. Lin D, et al. Among authors: wang y. Asian J Androl. 2014 May-Jun;16(3):407-12. doi: 10.4103/1008-682X.125394. Asian J Androl. 2014. PMID: 24589467 Free PMC article.

2

Development and characterization of efficient xenograft models for benign and malignant human prostate tissue.

Wang Y, Revelo MP, Sudilovsky D, Cao M, Chen WG, Goetz L, Xue H, Sadar M, Shappell SB, Cunha GR, Hayward SW. Wang Y, et al. Prostate. 2005 Jul 1;64(2):149-59. doi: 10.1002/pros.20225. Prostate. 2005. PMID: 15678503

3

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.

Wang Y, Xue H, Cutz JC, Bayani J, Mawji NR, Chen WG, Goetz LJ, Hayward SW, Sadar MD, Gilks CB, Gout PW, Squire JA, Cunha GR, Wang YZ. Wang Y, et al. Among authors: wang yz. Lab Invest. 2005 Nov;85(11):1392-404. doi: 10.1038/labinvest.3700335. Lab Invest. 2005. PMID: 16155594 Free article.

4

Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.

Cutz JC, Guan J, Bayani J, Yoshimoto M, Xue H, Sutcliffe M, English J, Flint J, LeRiche J, Yee J, Squire JA, Gout PW, Lam S, Wang YZ. Cutz JC, et al. Clin Cancer Res. 2006 Jul 1;12(13):4043-54. doi: 10.1158/1078-0432.CCR-06-0252. Clin Cancer Res. 2006. PMID: 16818704

5

Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy.

Doxsee DW, Gout PW, Kurita T, Lo M, Buckley AR, Wang Y, Xue H, Karp CM, Cutz JC, Cunha GR, Wang YZ. Doxsee DW, et al. Among authors: wang y, wang yz. Prostate. 2007 Feb 1;67(2):162-71. doi: 10.1002/pros.20508. Prostate. 2007. PMID: 17075799

6

The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.

Verras M, Lee J, Xue H, Li TH, Wang Y, Sun Z. Verras M, et al. Among authors: wang y. Cancer Res. 2007 Feb 1;67(3):967-75. doi: 10.1158/0008-5472.CAN-06-3552. Cancer Res. 2007. PMID: 17283128

7

The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases.

Lo M, Wang YZ, Gout PW. Lo M, et al. J Cell Physiol. 2008 Jun;215(3):593-602. doi: 10.1002/jcp.21366. J Cell Physiol. 2008. PMID: 18181196 Review.

8

ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.

Lin D, Watahiki A, Bayani J, Zhang F, Liu L, Ling V, Sadar MD, English J, Fazli L, So A, Gout PW, Gleave M, Squire JA, Wang YZ. Lin D, et al. Cancer Res. 2008 Jun 1;68(11):4352-9. doi: 10.1158/0008-5472.CAN-07-5237. Cancer Res. 2008. PMID: 18519696

9

The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.

Guan J, Lo M, Dockery P, Mahon S, Karp CM, Buckley AR, Lam S, Gout PW, Wang YZ. Guan J, et al. Cancer Chemother Pharmacol. 2009 Aug;64(3):463-72. doi: 10.1007/s00280-008-0894-4. Epub 2008 Dec 24. Cancer Chemother Pharmacol. 2009. PMID: 19104813

10

Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.

Gan L, Chen S, Wang Y, Watahiki A, Bohrer L, Sun Z, Wang Y, Huang H. Gan L, et al. Among authors: wang y. Cancer Res. 2009 Nov 1;69(21):8386-94. doi: 10.1158/0008-5472.CAN-09-1504. Epub 2009 Oct 13. Cancer Res. 2009. PMID: 19826044 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294,418 results

Search Page

Filters